Why the Industry is Testing the Wrong Thing The life sciences industry faces a growing paradox: organizations are investing heavily in AI, yet many evaluation methods fail to measure how these systems actually perform in real-world evidence synthesis workflows. Every week, new evaluations emerge, and task forces publish guidelines. Academic papers rank AI tools. Organizations…
How do you prepare a Clinical Evaluation Report (CER) without spending months on literature review and evidence synthesis? In this case study, MadeAi partnered with a medical device regulatory team to conduct a systematic literature review aligned with MDR and MEDDEV requirements. The team searched multiple databases, screened studies, extracted key evidence, and generated structured…
AI adoption in evidence synthesis often stalls when traceability, governance, and real-world validation requirements enter the picture. Most evaluations still focus on isolated models instead of the full systems used in regulated workflows. AI embeds human validation, workflow orchestration, auditability, and governance throughout the evidence-synthesis process, helping organizations build defensible, production-ready workflows. Download Rethinking…
The Systematic Literature Review Definition: Systematic Literature Review (SLR) is a rigorous, structured, and transparent process of identifying, analyzing, and synthesizing all existing research on a clearly defined question or topic, providing a comprehensive summary and critical evaluation of the evidence. If you’ve ever tried to pull together evidence for a big research question, you’ll know…
Watch the MadeAi Spring 2026 Highlights video now! Check out MadeAi’s exclusive Spring 2026 Highlights video featuring our CMO Meghan Oates-Zalesky and Head of Product Angeline Dhas, showcasing the latest AI-native capabilities shaping the future of evidence generation in life sciences. See how organizations are embracing AI-driven solutions from literature review and regulatory submissions to…
Today’s Reality vs. Future of Medical Affairs Imagine a seasoned oncologist in her clinic, preparing for morning rounds. Two decades ago, understanding the safety profile of a novel compound often meant waiting for a Medical Science Liaison (MSL) to deliver a curated slide deck. The MSL acted as a highly credible, yet fundamentally transactional, data…
